Cargando…
Influence of amiodarone treatment on inflammation during cardiopulmonary bypass
Autores principales: | Delle Karth, G, Buberl, A, Meyer, B, Zorn, G, Wojta, J, Wollenek, G, Grimm, M, Hiesmayer, M, Lassnig, A, Heinz, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098232/ http://dx.doi.org/10.1186/cc3145 |
Ejemplares similares
-
Monitoring of cardiac output in cardiogenic shock and low-output heart failure: LiDCO vs pulmonary artery catheter thermodilution
por: Meyer, B, et al.
Publicado: (2006) -
Pro-B-type natriuretic peptide predicts mortality in critically ill patients
por: Meyer, B, et al.
Publicado: (2005) -
Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006) -
Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004) -
Does cardiopulmonary bypass affect the procalcitonin level?
por: Kalay, F, et al.
Publicado: (2005)